Moderna Inc. on Thursday touted progress toward new vaccine approvals but said it will rein in its research and development spending and trim its pipeline as it looks to shake off the doldrums of a dwindling COVID vaccine market.
More Stories
Mercedes-Benz cuts guidance on slump in China’s economy
Mercedes-Benz shares fell 8% on Friday morning as the company cut its guidance for the second time since July
Treasury yields just shy of two-week highs amid optimism on the U.S. economy
Bond yields inched lower early Friday as as Wednesday’s jumbo rate cut by the Federal Reserve continued to be absorbed
Olympic skier Lindsey Vonn and boyfriend Diego Osorio slash the price of their $4.5 million Miami Beach home
The couple is offering a big discount on the 3,016-square-foot Florida dwelling after first listing it a year ago.
This is what the Fed’s interest-rate cut means for distressed companies
This week’s aggressive Fed rate cut could provide some breathing space for distressed companies, notes one bankruptcy attorney.
High-yield bond ETF rallies after Fed rate cut as ‘free ride’ in cash ends
Investors are mulling strategies beyond cash on expectations that interest rates will continue to fall after the Fed’s big rate...
Traders brace for volatility as more than $5 trillion in options set to expire in latest ‘triple witching’
It’s that time again: Investors will see option contracts tied to more than $5 trillion in tradeable stocks expire on...